Literature DB >> 16500432

Salivary gland tumors in survivors of childhood cancer.

W Stites Whatley1, Jerome W Thompson, Baskar Rao.   

Abstract

BACKGROUND: There is an increased incidence of second malignant neoplasms in survivors of childhood cancers. The most common second malignancies are acute leukemia, bone and soft tissue tumors, and carcinoma of the skin, breast, and thyroid. Although, ionizing radiation has been demonstrated to increase the risk of developing a salivary gland neoplasm, there are few reports of salivary gland neoplasms occurring in patients treated for cancer in childhood.
METHODS: A retrospective review of the patient registry of St. Jude Children's Research Hospital from 1963-2003.
RESULTS: Twelve survivors of childhood cancer developed a salivary gland neoplasm after completion of treatment. These patients were initially treated for a variety of childhood cancers with a combination of radiation and chemotherapy. The pathology of the salivary gland tumors were mucoepidermoid carcinoma (10), adenoid cystic carcinoma (1) , and pleomorphic adenoma (1). All patients were treated with surgical excision of the primary tumor, and postoperative radiation was added in select patients. Eleven patients were alive with no evidence of disease at last follow-up, and 1 patient was alive with clinical evidence of pulmonary metastasis.
CONCLUSION: Radiation and chemotherapy used to treat patients with childhood malignancies increases the risk of developing a second neoplasm of salivary gland origin. The majority of these neoplasms are malignant; mucoepidermoid carcinoma occurs most frequently. The treatment of these tumors includes surgical excision of the primary, with neck dissection in patients with clinical evidence of nodal metastasis, and postoperative radiation added for pathologies with adverse features. EBM RATING: C-4.

Entities:  

Mesh:

Year:  2006        PMID: 16500432     DOI: 10.1016/j.otohns.2005.10.022

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

Review 1.  Mutation-associated fusion cancer genes in solid tumors.

Authors:  Frederic J Kaye
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

2.  Salivary gland second cancer after bone sarcoma treatment.

Authors:  Alessandra Longhi; Costantino Errani; Marco Gambarotti; Christina Ferrari; Jennifer Kreshak; Georgios N Panagopoulos; Andreas F Mavrogenis; Davide Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-07-15

3.  Mucoepidermoid carcinoma of the posterior-lateral border of tongue: a rare presentation.

Authors:  Lisha Mathew; Mahija Janardhanan; Rakesh Suresh; Vindhya Savithri
Journal:  BMJ Case Rep       Date:  2017-10-24

4.  Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients.

Authors:  Zachary C Taylor; Erin A Kaya; Jeffrey D Bunn; Zachary D Guss; Brian J Mitchell; Robert K Fairbanks; Wayne T Lamoreaux; Aaron E Wagner; Ben J Peressini; Christopher M Lee
Journal:  World J Clin Oncol       Date:  2020-12-24

5.  MRI of radiation-induced tumors of the head and neck in post-radiation nasopharyngeal carcinoma.

Authors:  Jill M Abrigo; Ann D King; Sing Fai Leung; Alexander C Vlantis; Jeffrey K T Wong; Michael C F Tong; Gary M K Tse; Anil T Ahuja
Journal:  Eur Radiol       Date:  2009-01-14       Impact factor: 5.315

6.  GSTM1 and GSTT1 null polymorphisms and risk of salivary gland carcinoma.

Authors:  Sayaka Kondo; Erich M Sturgis; Fanglin Li; Qingyi Wei; Guojun Li
Journal:  Int J Clin Exp Med       Date:  2009-02-25

7.  Mucoepidermoid carcinoma of the sublingual gland harboring a translocation of the MAML2 gene: A case report.

Authors:  Kiminobu Sato; Jun Akiba; Ken Nakamura; Hideyuki Abe; Akihiko Kawahara; Takeichiro Aso; Hirohito Umeno; Hiroshi Harada; Hirohisa Yano
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.